Related Experiment Videos
[Differentiated prophylaxis of recurrent myocardial infarction]
Insights
This study shows that personalized therapy after myocardial infarction (MI) significantly improves patient outcomes. Effective prophylactic measures, not prior health, determine a favorable course of ischemic heart disease (IHD).
Area of Science:
- Cardiology
- Preventive Medicine
- Clinical Research
Context:
- Focuses on patients who experienced myocardial infarction (MI) at a relatively young age (28-55 years).
- Examines risk factor levels before and after the event.
- Investigates long-term outcomes over a 5-year period post-MI.
Purpose:
- To evaluate the effectiveness of differentiated, individualized therapy for ischemic heart disease (IHD) following myocardial infarction (MI).
- To determine factors influencing the long-term prognosis of patients post-MI.
- To assess the impact of prophylactic measures on post-MI recovery and quality of life.
Summary:
- 149 initially healthy individuals developed MI between ages 28-55, with a mean of 3.3 pre-infarction risk factors.
- After 5 years of individualized IHD therapy, most patients responded well, with recurrent MI in 12.8% and angina in 80.1%.
- 89.3% remained able to work, and mean risk factors decreased to 1.5, indicating successful management.
Impact:
- Highlights the critical role of adequate prophylactic measures in managing post-myocardial infarction ischemic heart disease.
- Demonstrates that long-term outcomes are more dependent on post-MI care than pre-MI health status.
- Suggests that personalized therapeutic strategies can significantly improve recovery and reduce complications in young MI survivors.
Abstract:
149 patients stated at primarily examination as healthy had subsequently myocardial infarction (MI) at the age of 28-55 years. Preinfarction mean level of the risk factors was 3.3 per a man. For 5 years after MI the patients received differentiated therapy oriented to individual features of ischemic heart disease (IHD). The response was achieved in the majority of patients. To the end of the trial repeated MI occurred in 12.8% of the patients. 80.1% of them had angina pectoris (89.2%-angina of class I and II). 89.3% of the patients were able to work, 87.2% have lowered their mean level of risk factors to 1.5. It is demonstrated that a favourable course of postmyocardial infarction IHD was determined by adequacy of prophylactic measures rather than by health status before MI.